The Defense Health Agency has awarded Leidos a five-year, $102.21 million contract to perform programmatic services in support of congressionally directed medical research initiatives and of U.S. Army Medical Research and Development Command subordinate organizations.
The contractor will assist program managers in conducting strategic planning, vision setting and programmatic review evaluation as well as in developing program announcements and broad agency announcements, the Department of Defense said Friday.
Leidos will also provide publicity and public affairs support to help the CDMRP gain review insights.
Work under the indefinite-delivery/indefinite-quantity contract will occur in Frederick, Maryland, from Feb. 1, 2023, to Jan. 31, 2028.
The Army Medical Research Acquisition Activity will obligate funds upon the issuance of the initial task order.
